Get with the guidelines: implementing risk-based type 2 diabetes care
This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only.
Find out more about how the current NICE Type 2 Diabetes Guidance can be applied to clinical practice, including discussion around adopting a cardiovascular-renal-metabolic mindset and a practical example of implementation in primary care.
AstraZeneca medicines will be mentioned during this presentation.
GB-58815, DOP: Sept 2024